GoodRx Holdings, Inc. - Common Stock (GDRX)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
135,951,844
Share change
-6,089,704
Total reported value
$632,167,610
Put/Call ratio
32%
Price per share
$4.65
Number of holders
162
Value change
-$55,077,631
Number of buys
88
Number of sells
81

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2024

As of 31 Dec 2024, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 135,951,844 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, Rubric Capital Management LP, LAKEWOOD CAPITAL MANAGEMENT, LP, AMERIPRISE FINANCIAL INC, Silver Lake Group, L.L.C., Petrus Trust Company, LTA, RENAISSANCE TECHNOLOGIES LLC, Rip Road Capital Partners LP, and MILLENNIUM MANAGEMENT LLC. This page lists 164 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.